查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1316488

细胞活力检测市场：按产品类型（消耗品、设备）、细胞类型（动物细胞、人类细胞、微生物细胞）、用途和最终用户 - 2023-2030 年全球预测

Cell Viability Assays Market by Product (Consumables, Instruments), Cell Type (Animal Cells, Human Cells, Microbial Cells), Application, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球细胞活力检测市场预计到2023年将大幅成长，达到17.9717亿美元，年复合成长率为11.31%，到2030年将达到38.2195亿美元。

FPNV定位矩阵

FPNV 定位矩阵对于评估全球细胞活力检测市场至关重要。透过检验业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 细胞活力检测的全球市场规模与预测为何？

2.在预测期内，COVID-19 对全球细胞活力检测市场的阻碍因素和影响为何？

3.在预测期内，全球细胞活力检测市场需要投资哪些产品/细分市场/用途/领域？

4. 全球细胞活力检测市场的竞争策略为何？

5.全球细胞活力检测市场的技术趋势和法律规范是什么？

6.全球细胞活力检测市场主要供应商的市占率为何？

7. 哪些型态和策略措施被认为适合进入全球细胞活力检测市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 增加细胞研究的投资
      • 各国临床试验数量增加
      • 利用细胞活力测定法来筛选水体
    • 抑制因素
      • 试剂和细胞活力测定的成本高昂
    • 机会
      • 开发用于细胞活力测定的高灵敏度和快速方案
      • 在品管操作中采用细胞活力
    • 任务
      • 细胞活力测定的技术限制
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章细胞活力测定市场：依产品

  • 介绍
  • 消耗品
  • 装置

第7章细胞活力测定市场：依细胞类型

  • 介绍
  • 动物细胞
  • 人体细胞
  • 微生物细胞

第8章细胞活力测定市场：依用途

  • 介绍
  • 基础研究
  • 临床和诊断用途
  • 药物研发发现与开发
  • 干细胞研究

第9章细胞活力测定市场：依最终用户分类

  • 介绍
  • 学术研究所
  • 医院和诊断实验室
  • 製药和生物技术公司

第10章美洲细胞活力检测市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第11章亚太细胞活力检测市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第12章欧洲、中东和非洲细胞活力检测市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第13章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第14章上市公司名单

第15章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-957C47F94DEA

The Global Cell Viability Assays Market is forecasted to grow significantly, with a projected USD 1,797.17 million in 2023 at a CAGR of 11.31% and expected to reach a staggering USD 3,821.95 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cell Viability Assays Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cell Viability Assays Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Consumables and Instruments. The Consumables is projected to witness significant market share during forecast period.

Based on Cell Type, market is studied across Animal Cells, Human Cells, and Microbial Cells. The Animal Cells is projected to witness significant market share during forecast period.

Based on Application, market is studied across Basic Research, Clinical & Diagnostic Applications, Drug Discovery & Development, and Stem Cell Research. The Drug Discovery & Development is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic & Research Institutes, Hospital & Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies. The Pharmaceutical & Biotechnology Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cell Viability Assays Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cell Viability Assays Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Viability Assays Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Viability Assays Market?

4. What is the competitive strategic window for opportunities in the Global Cell Viability Assays Market?

5. What are the technology trends and regulatory frameworks in the Global Cell Viability Assays Market?

6. What is the market share of the leading vendors in the Global Cell Viability Assays Market?

7. What modes and strategic moves are considered suitable for entering the Global Cell Viability Assays Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cell Viability Assays Market, by Product, 2022 vs 2030
  • 4.3. Cell Viability Assays Market, by Cell Type, 2022 vs 2030
  • 4.4. Cell Viability Assays Market, by Application, 2022 vs 2030
  • 4.5. Cell Viability Assays Market, by End-User, 2022 vs 2030
  • 4.6. Cell Viability Assays Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing investments in cell-based research
      • 5.1.1.2. Rising number of clinical trials in economies
      • 5.1.1.3. Utilization of cell viability assays to screen water bodies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of reagents and cell viability assays
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of highly sensitive and rapid protocol cell viability assays
      • 5.1.3.2. Adoption of cell viability in quality control operations
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations of cell viability assay
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Cell Viability Assays Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments

7. Cell Viability Assays Market, by Cell Type

  • 7.1. Introduction
  • 7.2. Animal Cells
  • 7.3. Human Cells
  • 7.4. Microbial Cells

8. Cell Viability Assays Market, by Application

  • 8.1. Introduction
  • 8.2. Basic Research
  • 8.3. Clinical & Diagnostic Applications
  • 8.4. Drug Discovery & Development
  • 8.5. Stem Cell Research

9. Cell Viability Assays Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospital & Diagnostic Laboratories
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Cell Viability Assays Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cell Viability Assays Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cell Viability Assays Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CELL VIABILITY ASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. CELL VIABILITY ASSAYS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CELL VIABILITY ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2022 VS 2030 (%)
  • FIGURE 6. CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 8. CELL VIABILITY ASSAYS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. CELL VIABILITY ASSAYS MARKET DYNAMICS
  • FIGURE 10. CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. CELL VIABILITY ASSAYS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. CELL VIABILITY ASSAYS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CELL VIABILITY ASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CELL VIABILITY ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. CELL VIABILITY ASSAYS MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CELL VIABILITY ASSAYS MARKET SIZE, BY HUMAN CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CELL VIABILITY ASSAYS MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. CELL VIABILITY ASSAYS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CELL VIABILITY ASSAYS MARKET SIZE, BY CLINICAL & DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CELL VIABILITY ASSAYS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. CELL VIABILITY ASSAYS MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. CELL VIABILITY ASSAYS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. CELL VIABILITY ASSAYS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. CELL VIABILITY ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. CELL VIABILITY ASSAYS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 189. CELL VIABILITY ASSAYS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 190. CELL VIABILITY ASSAYS MARKET LICENSE & PRICING